955 related articles for article (PubMed ID: 26743020)
1. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
[TBL] [Abstract][Full Text] [Related]
2. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
[TBL] [Abstract][Full Text] [Related]
3. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH; Syngelaki A; Poon LC; Gil MM; Wright D
Fetal Diagn Ther; 2014; 35(3):185-92. PubMed ID: 24192489
[TBL] [Abstract][Full Text] [Related]
4. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
[TBL] [Abstract][Full Text] [Related]
5. IONA test for first-trimester detection of trisomies 21, 18 and 13.
Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
[TBL] [Abstract][Full Text] [Related]
6. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
[TBL] [Abstract][Full Text] [Related]
8. Performance of the neoBona test: a new paired-end massively parallel shotgun sequencing approach for cell-free DNA-based aneuploidy screening.
Cirigliano V; Ordoñez E; Rueda L; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Apr; 49(4):460-464. PubMed ID: 27981672
[TBL] [Abstract][Full Text] [Related]
9. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
[TBL] [Abstract][Full Text] [Related]
11. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
Yankova M; Chaveeva P; Stratieva V
Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
[TBL] [Abstract][Full Text] [Related]
12. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
13. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.
Quezada MS; Gil MM; Francisco C; Oròsz G; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):36-41. PubMed ID: 25251385
[TBL] [Abstract][Full Text] [Related]
14. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
[TBL] [Abstract][Full Text] [Related]
15. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.
Galeva S; Gil MM; Konstantinidou L; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Jun; 53(6):804-809. PubMed ID: 30977206
[TBL] [Abstract][Full Text] [Related]
16. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
18. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.
Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):318-324. PubMed ID: 28833712
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
[TBL] [Abstract][Full Text] [Related]
20. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.
Gil MM; Quezada MS; Bregant B; Ferraro M; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):34-40. PubMed ID: 23744609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
